Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > New press release Pre-presentation.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(17)
•••
Comment by alphaseeking001on Dec 03, 2020 9:52am
106 Views
Post# 32025313

RE:RE:New press release Pre-presentation.

RE:RE:New press release Pre-presentation.Sorry, reposted without my comment.  I missed the webcast.  Any positive commentary from the analysts?  Any concerns from any of them?  The WF fellow has been hit or miss with us as us long's know!

casher wrote: this is great news! New ovarian cancer treatment on the way.

Great clinical benefit, LONG duration of response and very limited side effects on one of the most difficult cancers to treat.

There will be formalizing a plan to approach the FDA and pivotal trial expected in Q2

Highly encourage anyone interested to review the webcast




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities